NEOVISION CAPITAL
Neovision Capital was founded in 2015. Key founders are from Costone Capital, J.P. Morgan and so on. Leveraging its core teamโs rich China-operational experiences, international resources, and business acumen, we are actually dedicated to both early and growth-stage investment in healthcare and TMT sector in China. In order to leverage our core assets, we actively contribute expertise in essential services including branding, marketing, channel development, overseas expansion, human resources, and finance.
NEOVISION CAPITAL
Industry:
Asset Management Business Development Venture Capital
Founded:
2015-01-01
Status:
Active
Contact:
+8621 68581989
Email Addresses:
[email protected]
Technology used in webpage:
SPF ASP.NET IIS IIS 7 Alibaba ASP.NET 2.0 HiChina DNS Tencent QQ Mail
Similar Organizations
Apricot Capital
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry.
Ascendis Capital
Ascendis Capital is an investment platform that aims to create value in selected industries.
Metaplanet Holdings
Metaplanet Holdings is an early-stage investment firm that invests in diversified sectors.
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-07-15 | Sino-Biocan | Neovision Capital investment in Series A - Sino-Biocan | N/A |
2022-06-30 | Dakang Medical | Neovision Capital investment in Series E - Dakang Medical | 400 M CNY |
2022-06-27 | Xingsai Bio | Neovision Capital investment in Seed Round - Xingsai Bio | N/A |
2022-04-15 | Maibang Bio | Neovision Capital investment in Series B - Maibang Bio | 100 M CNY |
2022-01-28 | RzonTech | Neovision Capital investment in Venture Round - RzonTech | N/A |
2022-01-28 | Nuoyuan Medical | Neovision Capital investment in Venture Round - Nuoyuan Medical | N/A |
2021-12-28 | Matrixtime Robotics | Neovision Capital investment in Series A - Matrixtime Robotics | 100 M CNY |
2021-12-09 | ALVA Systems | Neovision Capital investment in Series B - ALVA Systems | N/A |
2021-11-05 | Xgene Pharmaceutical | Neovision Capital investment in Series C - Xgene Pharmaceutical | 40 M USD |
2021-10-01 | Chineo | Neovision Capital investment in Series B - Chineo | N/A |